TransMedics Group, Inc. TMDX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 28.48% | 25.82% | 30.24% | 37.13% | 41.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.48% | 25.82% | 30.24% | 37.13% | 41.20% |
| Cost of Revenue | 33.91% | 29.26% | 31.47% | 35.23% | 37.92% |
| Gross Profit | 24.90% | 23.51% | 29.41% | 38.43% | 43.45% |
| SG&A Expenses | 29.32% | 23.13% | 16.16% | 9.82% | 17.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.31% | 29.06% | 24.27% | 22.98% | 27.95% |
| Operating Income | -9.91% | 6.57% | 79.82% | 189.59% | 186.82% |
| Income Before Tax | -20.73% | -2.08% | 78.44% | 200.51% | 184.43% |
| Income Tax Expenses | -6,463.79% | -3,357.00% | -7,514.09% | -26,292.72% | 6,856.25% |
| Earnings from Continuing Operations | 57.42% | 111.69% | 251.23% | 436.58% | 181.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.42% | 111.69% | 251.23% | 436.58% | 181.16% |
| EBIT | -9.91% | 6.57% | 79.82% | 189.59% | 186.82% |
| EBITDA | 2.74% | 15.74% | 69.14% | 134.86% | 135.74% |
| EPS Basic | 55.43% | 108.84% | 244.82% | 421.46% | 173.50% |
| Normalized Basic EPS | -22.12% | -3.54% | 75.57% | 193.08% | 160.64% |
| EPS Diluted | 46.91% | 97.94% | 217.37% | 376.19% | 165.89% |
| Normalized Diluted EPS | -21.27% | -3.89% | 66.92% | 160.40% | 134.23% |
| Average Basic Shares Outstanding | 1.87% | 1.95% | 2.06% | 2.30% | 2.56% |
| Average Diluted Shares Outstanding | 1.43% | 4.76% | 8.44% | 15.11% | 11.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |